Evoq Remedies Ltd. (EVOQ.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-7336.2%

-₹119.40

vs ₹1.65 price

Levered DCF

-₹144.40

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

1.82

Grey zone

Rating

B-

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-25.2×	39.04×	29.61×	10.34×	11.28×	1.72×	2,928.57×	76.88×
P/B	0.14×	0.08×	0.53×	0.67×	0.53×	1.66×	38.64×	39.16×
P/S	0.24×	0.29×	2.11×	0.63×	0.73×	0.12×	0.1×	0.27×
EV / EBITDA	-30.58×	18.22×	28.12×	11.42×	11.88×	1.26×	1,754.2×	52.82×
Gross margin	0.1%	-11.3%	75.2%	26.8%	17.7%	21.6%	0.3%	0.7%
Operating margin	-5.9%	-19.4%	68.0%	8.7%	8.7%	20.5%	0.0%	0.7%
Net margin	-0.9%	0.8%	7.2%	6.1%	6.5%	7.1%	0.0%	0.3%
Current ratio	6.77×	9.1×	3.17×	3.45×	3.28×	1.1×	1.01×	1.01×
Debt / equity	0×	0×	0.17×	0.39×	0.35×	0×	0.27×	0.05×
Interest coverage	0×	0×	0×	0×	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-0.5%	0.2%	1.8%	6.5%	4.7%	96.3%	1.3%	49.8%
Return on invested capital	-3.2%	-3.5%	10.8%	4.7%	3.5%	207.4%	1.0%	66.7%
Return on assets	-0.5%	0.2%	1.2%	4.6%	3.3%	8.9%	0.0%	0.5%
Free cash flow yield	-4.7%	-432.5%	39.9%	-26.1%	-224.4%	2.5%	-2.5%	0.7%
Earnings yield	-4.0%	2.6%	3.4%	9.7%	8.9%	58.1%	0.0%	1.3%
Enterprise value	₹61.1M	₹32.3M	₹174M	₹261.5M	₹173.8M	₹12M	₹8.8M	₹8.6M
Net debt / EBITDA	-0.34×	-1.21×	6.65×	4.12×	3.46×	-0.03×	7.6×	-1.09×
Cash conversion cycle (days)	550	1,098	1,888	286	541	-59	46	-14